Jamieson, Dara G, MD PC

Jamieson, Dara G, MD PC is a sole proprietor medical practice based in New York providing independent medical expert services as a prime contractor to the federal government, operating exclusively under total small business set-asides on the majority of its individual task orders. The practice specializes in medical case review, analysis of medical records, preparation of expert medical opinions, and expert testimony to support evaluation and adjudication of vaccine injury claims filed under the National Vaccine Injury Compensation Program (VICP) administered by the Health Resources and Services Administration (HRSA).

The vendor operates as a for-profit subchapter S corporation classified under PSC Support—Professional: Expert Witness across its entire award portfolio. Jamieson's customer base is highly concentrated: HRSA accounts for 249 of 251 awards (99.6%) and the full $9.4 million in combined potential value, with the Department of Justice's US Attorney's Offices and Civil Division representing a single expert witness engagement of $5 thousand. The practice has maintained a significant presence in federal VICP work since at least December 2018, with recent activity declining year over year—45 awards in 2022, 61 in 2023, 39 in 2024, 9 in 2025, and 7 through June 2026.

Jamieson holds two single-award BPAs with HRSA Headquarters for medical expert services supporting the VICP. The primary vehicle, Blanket Purchase Agreement HSB114 C 7172, carries a $7.5 million ceiling through November 2027 (awarded November 4, 2022) and accounts for 124 task orders valued at approximately $993 thousand in combined potential value. A second, smaller BPA valued at $249,999 through May 2026 issued 67 task orders worth roughly $246 thousand. A third BPA, valued at $144 thousand across 55 task orders, extends through September 2025. Under these vehicles, HRSA issues firm fixed-price call orders ranging from $375 to $37,500, with the majority of individual task orders priced between $1,500 and $24,375. Representative work includes a $24,375 call issued June 26, 2026 for medical case review services under the larger BPA, and a $5,375 expert witness services order from the Department of Justice US Attorney's Offices in December 2023.

Task orders under the BPAs carry total small business set-aside designations, though the IDVs themselves are not formally designated set-asides. Jamieson competes predominantly under small business set-asides on individual calls, reflecting its small business posture across the portfolio. The recompete cliff shows 11 awards (combined potential value $268 thousand) reaching ultimate completion within the next twenty-four months, driven by the smaller, older BPA expiring in May 2026 and individual task orders with near-term completion dates. Obligated dollars across the portfolio stand at $1.4 million, representing 15% of combined potential value, indicating task order utilization remains well below ceiling capacity on the primary BPA vehicle. Work is performed entirely in New York, New York.